IIQ (IIQ) News
Follow IIQ (IIQ) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
INOVIQ Defines EXO-OC Commercialisation Path after Independent Review
INOVIQ ASX:IIQ has mapped a 12-to-18-month pathway to commercialise its EXO-OC ovarian cancer test as a US laboratory developed test (LDT), after an independent technical review supported its assessment of why the OC2200
NEWS | Sep 30, 2026, 12:18 AM UTC
L
Inoviq posts FY26 net loss after tax A$7.5 million
Inoviq reported FY26 net loss after tax of A$7.5 million.
EARNINGS | Aug 27, 2026, 01:23 AM UTC